ID

17835

Descripción

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains the Pharmacogenetic and Pharmacogenomic Research.

Palabras clave

Versiones (2)
  1. 4/10/16 4/10/16 -
  2. 5/12/16 5/12/16 -
Subido en

4 de octubre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

Inglés

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 formularios  
General Information
Descripción

General Information

Protocol Identifier: AVA100193
Descripción

Protocol Identifier

Tipo de datos

boolean

Subject Identifier
Descripción

Subject Identifier

Tipo de datos

integer

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Descripción

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research

Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
Descripción

Informed Consent

Tipo de datos

boolean

If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
Descripción

Date

Tipo de datos

date

If no, select one reason
Descripción

Reason for not obtaining informed consent

Tipo de datos

text

If Other, please specify
Descripción

Specification of Other

Tipo de datos

text

Blood sample collection (DNA)
Descripción

Blood sample collection (DNA)

Has a blood sample been collected for PGx-pharmacogenetic research?
Descripción

Has a blood sample been collected for PGx-pharmacogenetic research?

Tipo de datos

boolean

If yes, record the date samples taken.
Descripción

Date

Tipo de datos

date

Withdrawal of consent
Descripción

Withdrawal of consent

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Descripción

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?

Tipo de datos

boolean

Blood sample Destruction
Descripción

Blood sample Destruction

Has a request been made for sample destruction?
Descripción

Has a request been made for sample destruction?

Tipo de datos

boolean

If yes, specify reason
Descripción

If yes, specify reason

Tipo de datos

text

If other, please specify
Descripción

Other

Tipo de datos

text

Alias
UMLS CUI [1]
C0205394
Volver a la parte superior de la página

Similar models

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
General Information
Protocol Identifier
Item
Protocol Identifier: AVA100193
boolean
Subject Identifier
Item
Subject Identifier
integer
Item Group
PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Informed Consent
Item
Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
boolean
Date
Item
If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
date
Item
If no, select one reason
text
Reason for not obtaining informed consent
Code List
If no, select one reason
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator  (2)
CL Item
Other (specify) (3)
Specification of Other
Item
If Other, please specify
text
Item Group
Blood sample collection (DNA)
Has a blood sample been collected for PGx-pharmacogenetic research?
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
Date
Item
If yes, record the date samples taken.
date
Item Group
Withdrawal of consent
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Item
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
boolean
Item Group
Blood sample Destruction
Has a request been made for sample destruction?
Item
Has a request been made for sample destruction?
boolean
Item
If yes, specify reason
text
If yes, specify reason
Code List
If yes, specify reason
CL Item
Subject requested (1)
CL Item
Other (specify) (2)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial